Literature DB >> 15378659

Thrombin induces expression of cytokine-induced SH2 protein (CIS) in rat brain astrocytes: involvement of phospholipase A2, cyclooxygenase, and lipoxygenase.

Kyung-Ae Ji1, Myung-Soon Yang, Ilo Jou, Min-Ho Shong, Eun-Hye Joe.   

Abstract

Previously we have reported that thrombin induces inflammatory mediators in brain glial cells (Ryu et al. 2000. J Biol Chem 275:29955). In the present study, we found that thrombin induced a negative regulator of a cytokine signaling molecule, cytokine-induced SH2 protein (CIS), in rat brain astrocytes. In response to thrombin, CIS expression was increased at both the mRNA and protein levels. Although STAT5 is known to regulate CIS expression, thrombin did not activate STAT5, and inhibitors of JAK2 (AG490) and JAK3 (WHI-P97 and WHI-P154) had little effect on thrombin-induced CIS expression. In contrast, cytosolic phospholipase A(2) (cPLA(2)), cyclooxygenase (COX), and lipoxygenase (LO) play a role in CIS expression, since inhibitors of cPLA(2), cyclooxygenase (COX), and LO significantly reduced CIS expression. Reactive oxygen species (ROS) scavengers (N-acetyl-cysteine [NAC] and trolox) reduced thrombin-induced CIS expression, and inhibitors of COX and LO reduced ROS produced by thrombin. Furthermore, prostaglandin E(2) (PGE(2)) and leukotriene B(4) (LTB(4)), products of COX and LO, respectively, potentiated thrombin-induced CIS expression, indicating that ROS, and PGE(2) and LTB(4) generated by COX and LO, mediate CIS expression. Since interferon-gamma (IFN-gamma)-induced GAS-luciferase activity and tyrosine phosphorylation of STAT1 and STAT3 were lower in CIS-transfected cells compared to control vector-transfected cells, CIS could have anti-inflammatory activity. These data suggest that thrombin-stimulation of ROS and prostaglandin and leukotriene production via the cPLA(2), COX and LO pathways results in CIS expression. More importantly, CIS expression may be a negative feedback mechanism that prevents prolonged inflammatory responses.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15378659     DOI: 10.1002/glia.20059

Source DB:  PubMed          Journal:  Glia        ISSN: 0894-1491            Impact factor:   7.452


  8 in total

1.  Toluene diisocyanate (TDI) regulates haem oxygenase-1/ferritin expression: implications for toluene diisocyanate-induced asthma.

Authors:  S-H Kim; G-S Choi; Y-M Ye; I Jou; H-S Park; S M Park
Journal:  Clin Exp Immunol       Date:  2010-03-16       Impact factor: 4.330

2.  Systemic LPS administration induces brain inflammation but not dopaminergic neuronal death in the substantia nigra.

Authors:  Hey-Kyeong Jeong; Ilo Jou; Eun-hye Joe
Journal:  Exp Mol Med       Date:  2010-12-31       Impact factor: 8.718

3.  Involvement of PGE2 and PGDH but not COX-2 in thrombin-induced cortical neuron apoptosis.

Authors:  Lakshmi Thirumangalakudi; Haripriya Vittal Rao; Paula Grammas
Journal:  Neurosci Lett       Date:  2009-01-21       Impact factor: 3.046

4.  Isolation and culture of mouse primary pancreatic acinar cells.

Authors:  Johann Gout; Roxane M Pommier; David F Vincent; Bastien Kaniewski; Sylvie Martel; Ulrich Valcourt; Laurent Bartholin
Journal:  J Vis Exp       Date:  2013-08-13       Impact factor: 1.355

Review 5.  Astrocytes, Microglia, and Parkinson's Disease.

Authors:  Eun-Hye Joe; Dong-Joo Choi; Jiawei An; Jin-Hwa Eun; Ilo Jou; Sangmyun Park
Journal:  Exp Neurobiol       Date:  2018-04-24       Impact factor: 3.261

6.  Membrane lipid peroxidation in neurodegeneration: Role of thrombin and proteinase-activated receptor-1.

Authors:  Bruce A Citron; Syed Ameenuddin; K Uchida; William Z Suo; Karen SantaCruz; Barry W Festoff
Journal:  Brain Res       Date:  2016-04-30       Impact factor: 3.610

7.  Suppression of miR-155 Expression in IFN-γ-Treated Astrocytes and Microglia by DJ-1: A Possible Mechanism for Maintaining SOCS1 Expression.

Authors:  Jong-Hyeon Kim; Ilo Jou; Eun-Hye Joe
Journal:  Exp Neurobiol       Date:  2014-06-13       Impact factor: 3.261

Review 8.  The potential role of neuroinflammation and transcription factors in Parkinson disease.

Authors:  Prafulla Chandra Tiwari; Rishi Pal
Journal:  Dialogues Clin Neurosci       Date:  2017-03       Impact factor: 5.986

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.